PepGen Inc. Insider Trading Activity
Every SEC Form 4 insider transaction reported for PepGen Inc. (PEPG), sourced directly from SEC EDGAR and updated as new filings are accepted.
By Trabud · Insider-trading data from SEC EDGAR
Latest filing:
Compiled automatically from SEC EDGAR Form 4 filings and refreshed daily. Figures count purchases (code P) and sales (code S) only — not grants, option exercises, or gifts. How this page is built. Not investment advice.
Quick Answer
Are PEPG insiders buying or selling?
In the last 12 months, PepGen Inc. insiders reported 0 open-market purchases ($0) and 4 sales ($59.3K) — net selling of $59.3K. Since May 2022, Trabud has recorded 30 Form 4 filings for PEPG: 11 buys ($112.3M) and 19 sells ($1.7M).
Source: SEC EDGAR Form 4
Key Statistics (May 2022 – May 26, 2026)
Total Form 4 filings
30
SEC EDGAR
Insider filers
12
Insider buys (11)
$112.3M
Insider sells (19)
$1.7M
Insider sentiment
Net buyingNet insider flow of $110.6M in net buying since May 2022, and $59.3K in net selling over the last 12 months.
Recent PEPG insider transactions
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| May 26, 2026 | Kasra Kasraian | Chief Technical Officer | Sale | 1.2K | $1.41 | $1.7K | SEC ↗ |
| Mar 6, 2026 | Paul Streck | EVP, Head of R&D | Sale | 1.9K | $6.23 | $11.7K | SEC ↗ |
| Mar 6, 2026 | Noel Donnelly | Chief Financial Officer | Sale | 2.1K | $6.23 | $13.0K | SEC ↗ |
| Mar 6, 2026 | James G Mcarthur | President and CEO | Sale | 5.3K | $6.23 | $32.9K | SEC ↗ |
| Oct 1, 2025 | Oxford Science Enterprises plc | Other | Purchase | 200.0K | $3.20 | $640.0K | SEC ↗ |
| Sep 30, 2025 | Peter Kolchinsky | Director, 10% Owner | Purchase | 9.4M | $3.20 | $30.0M | SEC ↗ |
| Jun 2, 2025 | Paul Streck | EVP, Head of R&D | Purchase | 8.4K | $1.24 | $10.4K | SEC ↗ |
| Apr 22, 2025 | James G Mcarthur | President and CEO | Purchase | 10.0K | $1.36 | $13.6K | SEC ↗ |
| Apr 9, 2025 | James G Mcarthur | President and CEO | Purchase | 41.5K | $1.15 | $47.7K | SEC ↗ |
| Feb 27, 2025 | Mary Beth Delena | General Counsel | Sale | 1.4K | $1.68 | $2.4K | SEC ↗ |
| Feb 27, 2025 | Noel Donnelly | Chief Financial Officer | Sale | 1.5K | $1.68 | $2.6K | SEC ↗ |
| Jul 26, 2024 | Michelle L Mellion | Chief Medical Officer | Sale | 7.8K | $18.06 | $140.4K | SEC ↗ |
| Jul 19, 2024 | Michelle L Mellion | Chief Medical Officer | Sale | 12.6K | $18.20 | $229.8K | SEC ↗ |
| Jul 16, 2024 | Michelle L Mellion | Chief Medical Officer | Sale | 9.2K | $18.02 | $165.6K | SEC ↗ |
| Jul 3, 2024 | Michelle L Mellion | Chief Medical Officer | Sale | 912 | $18.01 | $16.4K | SEC ↗ |
| Jun 26, 2024 | Michelle L Mellion | Chief Medical Officer | Sale | 9.3K | $18.19 | $168.4K | SEC ↗ |
| Jun 13, 2024 | Michelle L Mellion | Chief Medical Officer | Sale | 1.6K | $18.06 | $28.6K | SEC ↗ |
| Jun 7, 2024 | Michelle L Mellion | SVP, Clinical Development | Sale | 8.7K | $18.08 | $156.5K | SEC ↗ |
| May 18, 2024 | Niels Svenstrup | SVP, Chem. Mfg & Controls | Sale | 10.0K | $13.41 | $134.1K | SEC ↗ |
| Apr 9, 2024 | Oxford Science Enterprises plc | 10% Owner | Purchase | 880.0K | $12.00 | $10.6M | SEC ↗ |
| Feb 13, 2024 | Peter Kolchinsky | Director, 10% Owner | Purchase | 2.6M | $10.64 | $27.2M | SEC ↗ |
| Dec 5, 2023 | James G Mcarthur | President and CEO | Purchase | 1.7K | $4.17 | $7.1K | SEC ↗ |
| Jun 9, 2023 | James G Mcarthur | President and CEO | Sale | 2.4K | $16.04 | $38.2K | SEC ↗ |
| Jun 8, 2023 | James G Mcarthur | President and CEO | Sale | 26.6K | $16.19 | $430.3K | SEC ↗ |
| Jun 6, 2023 | James G Mcarthur | President and CEO | Sale | 2.3K | $16.04 | $36.9K | SEC ↗ |
Showing the 25 most recent of 30 Form 4 filings for PepGen Inc..
Most active PEPG insiders
- James G Mcarthur7 filings
- Michelle L Mellion7 filings
- Peter Kolchinsky3 filings
- Jaya Goyal2 filings
- Noel Donnelly2 filings
Ask anything about PEPG insider activity
Use Trabud's AI agent to query PepGen Inc.'s Form 4 history in plain English — "Show me PEPG CEO purchases this year" or compare it against any other ticker.
Open the AI agentPEPG insider trading FAQ
Are PepGen Inc. insiders buying or selling?
In the last 12 months, PepGen Inc. insiders reported 0 open-market purchases ($0) and 4 sales ($59.3K) — net selling of $59.3K. Since May 2022, Trabud has recorded 30 Form 4 filings for PEPG: 11 buys ($112.3M) and 19 sells ($1.7M). Over the full record that is net buying of $110.6M.
How many insiders trade PEPG stock?
12 distinct insider filers — officers, directors, 10%+ owners, and investment groups filing jointly — have reported Form 4 transactions for PepGen Inc.. The most recent filing was accepted on May 26, 2026.
Where does Trabud get PEPG insider trading data?
All PEPG insider trading data comes directly from official SEC EDGAR Form 4 filings, which corporate insiders must submit within two business days of a transaction under Section 16(a) of the Securities Exchange Act of 1934.